ViroGates A/S

ViroGates A/S Dividend

Dividend of ViroGates A/S (VIRO.CO) as of Nov 22, 2026.

Dividend

0.00DKK

Last updated:

How much dividend does ViroGates A/S 2026 pay?

According to the latest status from November 2026, ViroGates A/S paid a total of 0.00 DKK per share in dividends within the last 12 months. With the current ViroGates A/S price of 6.05 DKK, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical ViroGates A/S Dividends

Historical ViroGates A/S Dividends
PaydateDividend

The ViroGates A/S Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2018
0.00 DKK
Jan 1, 2019
0.00 DKK
Jan 1, 2020
0.00 DKK
Jan 1, 2021
0.00 DKK
Jan 1, 2022
0.00 DKK
Jan 1, 2023
0.00 DKK
Jan 1, 2024
0.00 DKK
Jan 1, 2025
0.00 DKK
The ViroGates A/S Dividend history
YEARDividendYoY
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—
0.00DKK—

Is the ViroGates A/S Dividend Safe?

ViroGates A/S has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding ViroGates A/S's Dividend Distributions

ViroGates A/S’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining ViroGates A/S's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

ViroGates A/S's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in ViroGates A/S’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

ViroGates A/S Stock analysis

What does ViroGates A/S do? ViroGates A/S develops and markets prognostic products for the healthcare sector, focusing on the suPARnostic product line that measures soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The suPARnostic Quantitative Point of Care Quick Triage test is designed for patient triage in acute care settings, while the Quantitative ELISA Assay targets clinical routine use. Healthcare providers, including hospitals and clinics, purchase these products to assess immune activation levels and monitor disease progression, particularly for conditions like HIV-1-infection, malaria, tuberculosis, and sepsis. The company generates revenue through the sale of these diagnostic tools to healthcare institutions for use in patient care and disease management. The suPARnostic product line serves as a marker for survival chances upon hospital admission and aids in early intervention by detecting elevated suPAR levels linked to increased inflammation and mortality risk. High suPAR levels are associated with infectious diseases such as Streptococcus pneumonia bacteraemia, pneumococcal pneumonia, and bacterial and viral CNS infections. Healthcare facilities utilize the quantitative tests to determine patient prognosis and guide treatment decisions, ensuring timely interventions that improve patient outcomes. ViroGates A/S monetizes its diagnostic solutions by supplying healthcare systems with tools that enhance clinical decision-making and patient monitoring capabilities. ViroGates A/S targets healthcare providers who require rapid and accurate diagnostic tools for acute care and routine clinical use. The company's products are specifically tailored for monitoring immune activation in patients with infectious diseases, offering both point-of-care testing and laboratory-based assays. By providing these specialized diagnostic solutions, ViroGates A/S supports healthcare institutions in managing patient care more effectively, leading to better health outcomes and reduced mortality rates. Revenue is derived from the direct sale of suPARnostic tests to hospitals, clinics, and other clinical facilities that integrate these tools into their diagnostic workflows. ViroGates A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ViroGates A/S stock

ViroGates A/S paid dividends every year for the past 0 years.

ViroGates A/S is assigned to the 'Health' sector.

The dividends of ViroGates A/S are distributed in DKK.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — ViroGates A/S